Correction

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis

N Engl J Med 2005; 353:1640October 13, 2005

Article

Atorvastatin in Patients with Type 2 Diabetes Mellitus Undergoing Hemodialysis (Original Article, N Engl J Med 2005:353;238 - 248) . On page 243, in the continuation of Table 1, the dose of erythropoietin per week (IU) should have read “6225” for the placebo group and “6202” for the atorvastatin group, rather than “6.225” and “6.202,” respectively, as printed.

Citing Articles (1)

Citing Articles

1. 1

   Madhuri M. Vasudevan, Christie M. Ballantyne. (2009) Advances in Lipid Testing and Management in Patients with Diabetes Mellitus. Endocrine Practice 15:6, 641-652
   CrossRef